Tasly Pharmaceutical Group News

Tianshili (600535): Accelerate promotion of core varieties and efficient promotion of innovation pipelines

Aug 29 13:26

Tianshili (600535): China Resources is expected to enable the pipeline to advance in an orderly manner

Aug 27 16:52

Tianshi (600535): 2024H1 performance is relatively stable, pipeline innovation progresses steadily

Aug 26 18:06

Tianshili (600535): Pharmaceutical industry grows steadily, China Resources enters the market or enables high-quality development

Aug 26 00:00

Tianshili (600535): China Resources 39 returns the holding's interim dividend to shareholders

Aug 25 00:00

Tianshili (600535): Core assets have achieved steady growth, abundant R&D reserves, and are expected to accumulate and expand

Aug 25 00:00

Tianshi (600535): Performance is in line with expectations, R&D pipeline progresses rapidly

Aug 23 00:00

Tianshili (600535): State-owned investment is expected to enable new development and continuous strengthening of innovative R&D advantages in traditional Chinese medicine

Aug 7 15:56

Depth* Company* Tianshili (600535): Actual controller changes state-owned enterprise reform to embark on a new journey of modern traditional Chinese medicine development

Aug 7 09:16

Tianshili (600535): Signed the “Share Transfer Agreement” and China Resources 39 join hands to open a new situation of strong cooperation

Aug 6 19:36

Tianshili (600535): China Resources joins strong alliances; innovation leads high-quality development

Aug 6 16:31

Tianshili (600535): Jointly with China Resources's top 39 companies, they are optimistic about multi-dimensional empowerment to improve quality and efficiency

Aug 6 07:46

Tianshili (600535): Embracing State-owned assets collaboration and complementarity to consolidate its position as a leader in innovative traditional Chinese medicine

Aug 5 18:11

Research reports show that China Securities Co.,Ltd. believes that China Resources Sanjiu Medical & Pharmaceutical intends to acquire 28% of the equity of Tasly Pharmaceutical Group and maintains a "buy" rating.

Gelonghui FinanceAug 5 16:03

Tianshili (600535): Equity transfer plan launched and China Resources 39 joined hands to open a new chapter of development

Aug 5 14:26

Tianshi Li (600535): China Resources Joins Two-Way Empowerment - Tianshi Li Control Change Review

Aug 5 00:00

Tianshili (600535): Main product growth is steady, operating quality is healthy

May 4 13:26

Tianshili (600535): The R&D pipeline efficiently promotes performance growth in line with expectations

Apr 29 07:36

Tasly (600535): Steady growth in performance focuses on R&D progress

Apr 26 00:00

Tianshili (600535): Steady growth in performance, many highlights of the innovative R&D pipeline

Apr 25 08:46